# Huizenga Capital Management

> Huizenga Capital Management is a VC fund backing Medical and Health Care. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Oak Brook, United States
- Total investments: 3
- Last investment: May 2021
- Lead investor: 0%
- Last updated: Aug 2026

Huizenga Capital Management is an investment management company that specializes in overseas investments. It offers solutions in the fields of range of asset classes, including private equity, venture capital, hedge funds, public securities, real estate, and oil & gas. The company was founded in 1990 and headquartered in Oak Brook, Illinois.

## Contacts

5 contacts available for Huizenga Capital Management. Shizune tracks 1 team members at Huizenga Capital Management. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/huizenga-capital-management?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Retail | 1 | 33% |
| Handmade | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 67% |
| Series A | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Bradley | President | 0 | https://shizune.co/investors/profile/david-bradley-3 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HiberCell | HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York. | $67.4M | Series B | May 19, 2021 |  |
| Quince Therapeutics | Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currentlytesting several potential lead therapeutics in preclinical studies. | $76M | Series B | May 31, 2018 |  |
| Impossible Objects | Impossible Objects is a developer of a 3D printing technology used to make objects from sheets of kevlar, carbon fiber, and fiberglass. Its composite-based additive manufacturing (CBAM) technology combines high-performance polymers like nylon and PEEK with long-fiber carbon and fiberglass sheets to deliver complex parts at production speeds andvolumes that enable clients to churn out parts that are ready to use in cars, planes, computers, and more.It was founded in 2011 and is headquartered in Northbrook, Illinois. | $6.4M | Series A | Oct 10, 2017 |  |

3 of 3 investments shown.

## Co-investors
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 2 deals together
- [Breakout Ventures](https://shizune.co/investors/profile/breakoutventures) — VC Fund, 1 deal together
- [Bristol-Myers Squibb](https://shizune.co/investors/profile/bristol-myers-squibb) — VC Fund, 1 deal together
- [Dolby Family Ventures](https://shizune.co/investors/profile/dolby-family-ventures) — VC Fund, 1 deal together
- [EPIQ Capital Group](https://shizune.co/investors/profile/epiq-capital-group) — VC Fund, 1 deal together
- [IDEA Fund Partners](https://shizune.co/investors/profile/idea-fund-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Huizenga Capital Management invest in?

Huizenga Capital Management invests primarily in Medical, Health Care and Biotechnology startups, most often at Series B and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Huizenga Capital Management?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Huizenga Capital Management?

The team at Huizenga Capital Management includes David Bradley (President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co